Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Clin Infect Dis ; 69(Suppl 2): S89-S96, 2019 09 05.
Artículo en Inglés | MEDLINE | ID: mdl-31505622

RESUMEN

BACKGROUND: Global surveillance for vaccine preventable invasive bacterial diseases has been set up by the World Health Organization to provide disease burden data to support decisions on introducing pneumococcal conjugate vaccine (PCV). We present data from 2010 to 2016 collected at the 2 sentinel sites in Ghana. METHODS: Data were collected from children <5 years of age presenting at the 2 major teaching hospitals with clinical signs of meningitis. Cerebrospinal fluid specimens were collected and tested first at the sentinel site laboratory with conventional microbiology methods and subsequently with molecular analysis, at the World Health Organization Regional Reference Laboratory housed at the Medical Research Council Unit The Gambia, for identification of Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, the 3 most common bacteria causing meningitis. RESULTS: There were 4008 suspected cases of meningitis during the surveillance period, of which 31 (0.8%) were laboratory confirmed. Suspected meningitis cases decreased from 923 in 2010 to 219 in 2016. Of 3817 patients with available outcome data, 226 (5.9%) died. S. pneumoniae was the most common bacterial pathogen, accounting for 68.5% of confirmed cases (50 of 73). H. influenzae and N. meningitidis accounted for 6.8% (5 of 73) and 21.9% (16 of 73), respectively. The proportion of pneumococcal vaccine serotypes causing meningitis decreased from 81.3% (13 of 16) before the introduction of 13-valent PCV (2010-2012) to 40.0% (8 of 20) after its introduction (2013-2016). CONCLUSIONS: Cases of suspected meningitis decreased among children <5 years of age between 2010 and 2016, with declines in the proportion of vaccine-type pneumococcal meningitis after the introduction of 13-valent PCV in Ghana.


Asunto(s)
Hospitales/estadística & datos numéricos , Meningitis Bacterianas/epidemiología , Meningitis Bacterianas/prevención & control , Vacunas Neumococicas/administración & dosificación , Vigilancia de Guardia , Preescolar , Costo de Enfermedad , Femenino , Ghana/epidemiología , Haemophilus influenzae , Humanos , Lactante , Recién Nacido , Masculino , Meningitis Bacterianas/mortalidad , Neisseria meningitidis , Streptococcus pneumoniae , Organización Mundial de la Salud
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda